Sphingosine-1-phosphate receptor 2

被引:108
作者
Adada, Mohamad [1 ]
Canals, Daniel [1 ]
Hannun, Yusuf A. [1 ]
Obeid, Lina M. [1 ,2 ]
机构
[1] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA
[2] Northport VA Med Ctr, Northport, NY USA
基金
美国国家卫生研究院;
关键词
cancer; ceramide; ezrin; JTE013; S1P knockout mouse; S1PR2; SID46371153; sphingolipid diseases; sphingolipids; sphingosine; 1-phosphate; SPHINGOSINE 1-PHOSPHATE RECEPTOR; PROTEIN-COUPLED RECEPTOR; CELL-PROLIFERATION; LYMPHOCYTE EGRESS; MOLECULAR-CLONING; SMOOTH-MUSCLE; MICE LACKING; ACTIVATION; MIGRATION; INHIBITION;
D O I
10.1111/febs.12446
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine-1-phosphate (S1P) is a potent bioactive sphingolipid involved in cell proliferation, angiogenesis, inflammation and malignant transformation among other functions. S1P acts either directly on intracellular targets or activates G protein-coupled receptors, specifically five S1P receptors (S1PRs). The identified S1PRs differ in cellular and tissue distribution, and each is coupled to specific Gproteins, which mediate unique functions. Here, we describe functional characteristics of all five receptors, emphasizing S1PR2, which is critical in the immune, nervous, metabolic, cardiovascular, musculoskeletal, and renal systems. This review also describes the role of this receptor in tumor growth and metastasis and suggests potential therapeutic avenues that exploit S1PR2.
引用
收藏
页码:6354 / 6366
页数:13
相关论文
共 93 条
[81]   Inside-Out signaling of sphingosine-1-phosphate: Therapeutic targets [J].
Takabe, Kazuaki ;
Paugh, Steven W. ;
Milstien, Sheldon ;
Spiegel, Sarah .
PHARMACOLOGICAL REVIEWS, 2008, 60 (02) :181-195
[82]   G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase [J].
Takashima, Shin-ichiro ;
Sugimoto, Naotoshi ;
Takuwa, Noriko ;
Okamoto, Yasuo ;
Yoshioka, Kazuaki ;
Takamura, Masayuki ;
Takata, Shigeo ;
Kaneko, Shuichi ;
Takuwa, Yoh .
CARDIOVASCULAR RESEARCH, 2008, 79 (04) :689-697
[83]   Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier [J].
van Doom, Ruben ;
Pinheiro, Melissa A. Lopes ;
Kooij, Gijs ;
Lakeman, Kim ;
Hof, Bert van Het ;
van der Pol, Susanne M. A. ;
Geerts, Dirk ;
van Horssen, Jack ;
van der Valk, Paul ;
van der Kam, Elizabeth ;
Ronken, Eric ;
Reijerkerk, Arie ;
de Vries, Helga E. .
JOURNAL OF NEUROINFLAMMATION, 2012, 9
[84]   Sphingosine 1-Phosphate Receptor 1 and 3 Are Upregulated in Multiple Sclerosis Lesions [J].
Van Doorn, Ruben ;
Van Horssen, Jack ;
Verzijl, Dennis ;
Witte, Maarten ;
Ronken, Eric ;
Hof, Bert Van Het ;
Lakeman, Kim ;
Dijkstra, Christine D. ;
Van der Valk, Paul ;
Reijerkerk, Arie ;
Alewijnse, Astrid E. ;
Peters, Stephan L. M. ;
De Vries, Helga E. .
GLIA, 2010, 58 (12) :1465-1476
[85]   Activation of a high affinity G(i) protein-coupled plasma membrane receptor by sphingosine-1-phosphate [J].
vanKoppen, CJ ;
Heringdorf, DMZ ;
Laser, KT ;
Zhang, CY ;
Jakobs, KH ;
Bunemann, M ;
Pott, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2082-2087
[86]   Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor [J].
Walzer, Thierry ;
Chiossone, Laura ;
Chaix, Julie ;
Calver, Andrew ;
Carozzo, Claude ;
Garrigue-Antar, Laure ;
Jacques, Yannick ;
Baratin, Myriam ;
Tomasello, Elena ;
Vivier, Eric .
NATURE IMMUNOLOGY, 2007, 8 (12) :1337-1344
[87]   Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration [J].
Wang, WG ;
Graeler, MH ;
Goetzl, EJ .
FASEB JOURNAL, 2005, 19 (09) :1731-+
[88]   Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9 [J].
Yamaguchi, F ;
Tokuda, M ;
Hatase, O ;
Brenner, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 227 (02) :608-614
[89]   Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells [J].
Yamaguchi, H ;
Kitayama, J ;
Takuwa, N ;
Arikawa, K ;
Inoki, I ;
Takehara, K ;
Nagawa, H ;
Takuwa, Y .
BIOCHEMICAL JOURNAL, 2003, 374 :715-722
[90]   Fingolimod: an Oral Disease-Modifying Therapy for Relapsing Multiple Sclerosis [J].
Yeh, E. Ann ;
Weinstock-Guttman, B. .
ADVANCES IN THERAPY, 2011, 28 (04) :270-278